Cargando…

Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort study

Detalles Bibliográficos
Autores principales: Hamilton, B K, Rybicki, L, Haddad, H, Abounader, D, Yurch, M, Majhail, N S, Hanna, R, Sobecks, R, Dean, R, Liu, H, Hill, B, Copelan, E, Bolwell, B, Kalaycio, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558594/
https://www.ncbi.nlm.nih.gov/pubmed/26314986
http://dx.doi.org/10.1038/bcj.2015.70
_version_ 1782388643611017216
author Hamilton, B K
Rybicki, L
Haddad, H
Abounader, D
Yurch, M
Majhail, N S
Hanna, R
Sobecks, R
Dean, R
Liu, H
Hill, B
Copelan, E
Bolwell, B
Kalaycio, M
author_facet Hamilton, B K
Rybicki, L
Haddad, H
Abounader, D
Yurch, M
Majhail, N S
Hanna, R
Sobecks, R
Dean, R
Liu, H
Hill, B
Copelan, E
Bolwell, B
Kalaycio, M
author_sort Hamilton, B K
collection PubMed
description
format Online
Article
Text
id pubmed-4558594
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-45585942015-09-14 Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort study Hamilton, B K Rybicki, L Haddad, H Abounader, D Yurch, M Majhail, N S Hanna, R Sobecks, R Dean, R Liu, H Hill, B Copelan, E Bolwell, B Kalaycio, M Blood Cancer J Letter to the Editor Nature Publishing Group 2015-08 2015-08-28 /pmc/articles/PMC4558594/ /pubmed/26314986 http://dx.doi.org/10.1038/bcj.2015.70 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
Hamilton, B K
Rybicki, L
Haddad, H
Abounader, D
Yurch, M
Majhail, N S
Hanna, R
Sobecks, R
Dean, R
Liu, H
Hill, B
Copelan, E
Bolwell, B
Kalaycio, M
Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort study
title Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort study
title_full Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort study
title_fullStr Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort study
title_full_unstemmed Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort study
title_short Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort study
title_sort does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? results from a single-center retrospective cohort study
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558594/
https://www.ncbi.nlm.nih.gov/pubmed/26314986
http://dx.doi.org/10.1038/bcj.2015.70
work_keys_str_mv AT hamiltonbk doesday11omissionofmethotrexateduetotoxicityinfluencetheoutcomeinmyeloablativehematopoieticcelltransplantresultsfromasinglecenterretrospectivecohortstudy
AT rybickil doesday11omissionofmethotrexateduetotoxicityinfluencetheoutcomeinmyeloablativehematopoieticcelltransplantresultsfromasinglecenterretrospectivecohortstudy
AT haddadh doesday11omissionofmethotrexateduetotoxicityinfluencetheoutcomeinmyeloablativehematopoieticcelltransplantresultsfromasinglecenterretrospectivecohortstudy
AT abounaderd doesday11omissionofmethotrexateduetotoxicityinfluencetheoutcomeinmyeloablativehematopoieticcelltransplantresultsfromasinglecenterretrospectivecohortstudy
AT yurchm doesday11omissionofmethotrexateduetotoxicityinfluencetheoutcomeinmyeloablativehematopoieticcelltransplantresultsfromasinglecenterretrospectivecohortstudy
AT majhailns doesday11omissionofmethotrexateduetotoxicityinfluencetheoutcomeinmyeloablativehematopoieticcelltransplantresultsfromasinglecenterretrospectivecohortstudy
AT hannar doesday11omissionofmethotrexateduetotoxicityinfluencetheoutcomeinmyeloablativehematopoieticcelltransplantresultsfromasinglecenterretrospectivecohortstudy
AT sobecksr doesday11omissionofmethotrexateduetotoxicityinfluencetheoutcomeinmyeloablativehematopoieticcelltransplantresultsfromasinglecenterretrospectivecohortstudy
AT deanr doesday11omissionofmethotrexateduetotoxicityinfluencetheoutcomeinmyeloablativehematopoieticcelltransplantresultsfromasinglecenterretrospectivecohortstudy
AT liuh doesday11omissionofmethotrexateduetotoxicityinfluencetheoutcomeinmyeloablativehematopoieticcelltransplantresultsfromasinglecenterretrospectivecohortstudy
AT hillb doesday11omissionofmethotrexateduetotoxicityinfluencetheoutcomeinmyeloablativehematopoieticcelltransplantresultsfromasinglecenterretrospectivecohortstudy
AT copelane doesday11omissionofmethotrexateduetotoxicityinfluencetheoutcomeinmyeloablativehematopoieticcelltransplantresultsfromasinglecenterretrospectivecohortstudy
AT bolwellb doesday11omissionofmethotrexateduetotoxicityinfluencetheoutcomeinmyeloablativehematopoieticcelltransplantresultsfromasinglecenterretrospectivecohortstudy
AT kalayciom doesday11omissionofmethotrexateduetotoxicityinfluencetheoutcomeinmyeloablativehematopoieticcelltransplantresultsfromasinglecenterretrospectivecohortstudy